Citadel Advisors’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.15M Buy
171,700
+148,400
+637% +$2.82M ﹤0.01% 5173
2025
Q4
$367K Sell
23,300
-43,200
-65% -$771K ﹤0.01% 9719
2025
Q3
$1.29M Sell
66,500
-9,900
-13% -$193K ﹤0.01% 6993
2025
Q2
$1.58M Sell
76,400
-7,800
-9% -$162K ﹤0.01% 6168
2025
Q1
$2.06M Sell
84,200
-1,300
-2% -$33.4K ﹤0.01% 5482
2024
Q4
$2.05M Sell
85,500
-19,400
-18% -$616K ﹤0.01% 5572
2024
Q3
$4.45M Sell
104,900
-3,800
-3% -$199K ﹤0.01% 4128
2024
Q2
$5.57M Sell
108,700
-1,700
-2% -$96.3K ﹤0.01% 3580
2024
Q1
$6.9M Buy
110,400
+61,900
+128% +$4.21M ﹤0.01% 3467
2023
Q4
$3.63M Buy
48,500
+5,000
+11% +$358K ﹤0.01% 4316
2023
Q3
$3.71M Sell
43,500
-52,100
-54% -$4.94M ﹤0.01% 4130
2023
Q2
$10.4M Buy
95,600
+19,800
+26% +$1.88M ﹤0.01% 2618
2023
Q1
$6.29M Sell
75,800
-5,800
-7% -$546K ﹤0.01% 3441
2022
Q4
$8.39M Sell
81,600
-47,400
-37% -$5.46M ﹤0.01% 3063
2022
Q3
$13.7M Buy
129,000
+68,800
+114% +$7.54M ﹤0.01% 2344
2022
Q2
$6.61M Sell
60,200
-132,700
-69% -$13.1M ﹤0.01% 3309
2022
Q1
$20.1M Buy
192,900
+16,300
+9% +$1.69M ﹤0.01% 1979
2021
Q4
$21.6M Buy
176,600
+122,300
+225% +$13.6M ﹤0.01% 1925
2021
Q3
$6.23M Buy
54,300
+28,800
+113% +$3.05M ﹤0.01% 3897
2021
Q2
$2.47M Sell
25,500
-500
-2% -$43.4K ﹤0.01% 6077
2021
Q1
$1.92M Buy
26,000
+8,600
+49% +$639K ﹤0.01% 6483
2020
Q4
$1.19M Sell
17,400
-35,400
-67% -$2.31M ﹤0.01% 6430
2020
Q3
$3.09M Sell
52,800
-21,300
-29% -$1.12M ﹤0.01% 3937
2020
Q2
$3.35M Buy
74,100
+58,800
+384% +$2.81M ﹤0.01% 3670
2020
Q1
$884K Buy
15,300
+4,300
+39% +$294K ﹤0.01% 5550
2019
Q4
$685K Sell
11,000
-8,200
-43% -$485K ﹤0.01% 6289
2019
Q3
$1.1M Buy
19,200
+1,300
+7% +$71.9K ﹤0.01% 5428
2019
Q2
$971K Sell
17,900
-9,900
-36% -$502K ﹤0.01% 5744
2019
Q1
$1.31M Buy
27,800
+3,300
+13% +$183K ﹤0.01% 5130
2018
Q4
$1.39M Buy
24,500
+9,100
+59% +$510K ﹤0.01% 4760
2018
Q3
$842K Sell
15,400
-3,800
-20% -$218K ﹤0.01% 5837
2018
Q2
$1.13M Buy
19,200
+8,100
+73% +$483K ﹤0.01% 5013
2018
Q1
$630K Sell
11,100
-8,900
-45% -$484K ﹤0.01% 5503
2017
Q4
$985K Buy
20,000
+6,500
+48% +$296K ﹤0.01% 4681
2017
Q3
$617K Sell
13,500
-1,000
-7% -$38.2K ﹤0.01% 5007
2017
Q2
$566K Sell
14,500
-5,300
-27% -$203K ﹤0.01% 4938
2017
Q1
$804K Buy
19,800
+2,300
+13% +$90.1K ﹤0.01% 4319
2016
Q4
$673K Buy
17,500
+9,900
+130% +$338K ﹤0.01% 4449
2016
Q3
$242K Hold
7,600
﹤0.01% 6022
2016
Q2
$304K Sell
7,600
-27,500
-78% -$1.02M ﹤0.01% 5193
2016
Q1
$1.18M Buy
35,100
+23,400
+200% +$669K ﹤0.01% 3273
2015
Q4
$363K Sell
11,700
-7,900
-40% -$234K ﹤0.01% 4933
2015
Q3
$588K Buy
19,600
+9,300
+90% +$307K ﹤0.01% 4566
2015
Q2
$325K Sell
10,300
-2,700
-21% -$70.5K ﹤0.01% 5639
2015
Q1
$300K Buy
+13,000
New +$269K ﹤0.01% 5649
2014
Q4
Sell
-7,300
Closed -$115K 8457
2014
Q3
$115K Buy
7,300
+5,100
+232% +$72.7K ﹤0.01% 6282
2014
Q2
$27K Buy
2,200
+1,300
+144% +$15.5K ﹤0.01% 7134
2014
Q1
$12K Sell
900
-9,300
-91% -$134K ﹤0.01% 7454
2013
Q4
$150K Buy
10,200
+6,100
+149% +$82.6K ﹤0.01% 5283
2013
Q3
$56K Sell
4,100
-3,600
-47% -$52.9K ﹤0.01% 5722
2013
Q2
$110K Buy
+7,700
New +$108K ﹤0.01% 5149

Other funds holding AMN

Citadel Advisors's AMN Position: Q1 2026 in Review

Citadel Advisors reduced its AMN Healthcare (AMN) stake by 27% in Q1 2026, selling an estimated $2.72M and leaving 378,564 shares worth $6.94M. The position accounts for ﹤0.01% of the portfolio, ranked #3823.

Citadel Advisors first reported a position in AMN in Q2 2013 and has held it in 44 quarters since. The position peaked at $44.3M in Q2 2023. 249 funds tracked by Wall St. Rank hold AMN as of Q1 2026.

  • Citadel Advisors held 378,564 shares of AMN Healthcare worth $6.94M as of Q1 2026.
  • Citadel Advisors sold 143,156 AMN Healthcare shares in Q1 2026, an estimated $2.72M.
  • AMN Healthcare made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #3823 holding.
  • Citadel Advisors first reported a position in AMN Healthcare in Q2 2013 and has held it in 44 quarters since.
  • Citadel Advisors's AMN Healthcare position peaked at $44.3M in Q2 2023.
  • 249 funds tracked by Wall St. Rank held AMN Healthcare as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.